Skip to content

The Effect of Intravenous Dexmedetomidine for Prevention of Shivering During and Post Cesarean Section with Spinal Anesthesia

Prevention of Shivering During and Post Cesarean Section with Spinal Anesthesia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016070210765N9
Enrollment
70
Registered
2016-12-10
Start date
2016-11-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypothermia following anaesthesia. Other complications of anaesthesia(Hypothermia following anaesthesia)

Interventions

Intervention 1: Intervention or dexmedotomidine group will be administered 1 µg/kg dexmedotomidine in 20 ml normal saline immediately after delivery and cord clamping. Intervention 2: Control group w
Treatment - Drugs
Placebo
Intervention or dexmedotomidine group will be administered 1 µg/kg dexmedotomidine in 20 ml normal saline immediately after delivery and cord clamping.
Control group will receive normal saline as placebo in the same volume.

Sponsors

Research center, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 42 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: parturients aged 18-42 years old; patients with ASA class I & II; patients signed informed consent. Exclusion criteria: parturients with ASA class III or high; contraindication for spinal anesthesia; diabetics; preterm labor; hypertension; preeclampsia and eclampsia; allergy; drug or alcohol abuse; cardiovascular disease; respiratory disease; renal and hepatic disease; hypo or hyperthermic disease.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of shivering. Timepoint: Intra and postoperative. Method of measurement: Crossley and Mahjon scale.

Secondary

MeasureTime frame
Mepridine requairments. Timepoint: Intra and postoperative. Method of measurement: Crossley and Mahjon scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSousan Rasouli

Reaserch center, Tabriz University of Medical Scienses

rasooli_s@yahoo.com+98 41 3553 9161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026